Skip to main content
. Author manuscript; available in PMC: 2017 Aug 21.
Published in final edited form as: Contemp Clin Trials. 2016 Jul 25;50:84–89. doi: 10.1016/j.cct.2016.07.015

Table 1.

Patient Demographics, Disease, and Tobacco-Use Characteristics at Study Enrollment

SRP UC Total
Characteristics n = 204 n = 210 N = 414
M (SD) or (N, %) M (SD) or (N, %) M (SD) or (N, %)
Gender (Female) 102 (50.0%) 106 (51.0%) 208 (50.2%)
Age 55.0 (11.0) 55.0 (10.5) 55.0 (10.7)
Race
  White 193 (95.0%) 189 (90.0%) 382 (92.3%)
  Black/African American 3 (1.0%) 10 (5.0%) 13 (3.1%)
  Other 4 (2.0%) 7 (3.0%) 11 (2.7%)
Hispanic ethnicity 13 (6.0%) 16 (8.0%) 29 (7.0%)
Marital Status: Married or living with a partner 113 (55.0%) 111 (53.0%) 224 (54.0%)
Education: High school graduate or below 94 (46.0%) 96 (46.0%) 190 (46.0%)
Income: Below $30,000/year 84 (41.0%) 86 (41.0%) 170 (41.0%)
Employed 117 (57.0%) 112 (53.3%) 229 (55.3%)
Financial concerns regarding cancer Dx/Tx: Yes 122 (59.8%) 128 (60.9%) 250 (60.3%)
Current financial situation
  Difficult/Very Difficult 58 (28.4%) 58 (27.6%) 116 (28.0%)
Cancer Site
  Thoracic 43 (21.1%) 45 (21.4%) 88 (21.3%)
  Head &Neck 38 (18.6%) 38 (18.1%) 76 (18.4%)
  Gastrointestinal 25 (12.3%) 26 (12.4%) 51 (12.3%)
  Genitourinary 26 (12.8%) 17 (8.1%) 43 (10.4%)
  Breast 22 (10.8%) 26 (12.4%) 47 (11.6%)
  Gynecological 20 (9.8%) 16 (7.6%) 36 (8.7%)
  Hematological 16 (7.8%) 25 (11.9%) 41 (9.9%)
  Cutaneous 10 (4.9%) 10 (4.8%) 20 (4.8%)
  Other 4 (2.0%) 7 (3.3%) 11 (2.7%)
Disease stage (TNM)
  Unstaged 20 (9.8%) 38 (18.1%) 58 (14.0%)
  Stage 0 7 (3.4%) 2 (1.0%) 9 (2.2%)
  Early (I–II) 111 (54.4%) 90 (42.9%) 201 (48.6%)
  Late (III–IV) 66 (32.4%) 80 (38.1%) 146 (35.3%)
Smoking-related variables
  Cigarettes per day 21.6 (9.4) 20.3 (9.6) 21.0 (9.5)
  Number of years smoking 35.0 (12.6) 34.3 (11.5) 34.6 (12.1)
  Fagerström Test for Nicotine Dependence 5.3 (2.1) 5.0 (2.2) 5.1 (2.2)
  Quitting self-efficacy 37.9 (7.6) 38.4 (7.5) 38.2 (7.6)